Antibody-endostatin fusion protein and its variants

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9611313
SERIAL NO

14254333

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods of inhibiting the growth of tumors comprising administering chimeric fusion molecules comprising endostatin mutants and all or a portion of anti-Her2 or anti-EGFR antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF MIAMI1951 NW 7TH AVENUE MIAMI FL 33136

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Morrison, Sherie L Los Angeles, US 32 1699
Rosenblatt, Joseph David Miami, US 2 20
Shin, Seung-Uon Miami, US 9 111

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 4, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00